ChemicalBook >> CAS DataBase List >>Ki8751

Ki8751

CAS No.
228559-41-9
Chemical Name:
Ki8751
Synonyms
Ki8751;CS-532;Ki8751, >=98%;Ki8751 hydrate;KI 8751; KI-8751;Ki8751 USP/EP/BP;KI8751;KI 8751;KI-8751;VEGFR2 Kinase Inhibitor VI, Ki8751;VEGFR2 Kinase Inhibitor VI Ki8751 Ki-8751;VEGFR2 Kinase Inhibitor VI, Ki8751 - CAS 228559-41-9 - Calbiochem
CBNumber:
CB71074331
Molecular Formula:
C24H18F3N3O4
Molecular Weight:
469.41
MDL Number:
MFCD09971092
MOL File:
228559-41-9.mol
MSDS File:
SDS
Last updated:2023-06-30 15:45:59

Ki8751 Properties

Melting point 239℃
Density 1.429
storage temp. −20°C
solubility Soluble in DMSO (15 mg/ml)
form Off-white solid
color White
Stability Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
FDA UNII RP6UGT29FF

SAFETY

Risk and Safety Statements

Hazard Codes  Xn
Risk Statements  22-38
Safety Statements  37

Ki8751 price More Price(35)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich 676484 VEGFR2 Kinase Inhibitor VI, Ki8751 228559-41-9 5mg $303 2024-03-01 Buy
Cayman Chemical 18004 Ki8751 ≥98% 228559-41-9 5mg $61 2024-03-01 Buy
Cayman Chemical 18004 Ki8751 ≥98% 228559-41-9 10mg $112 2024-03-01 Buy
Cayman Chemical 18004 Ki8751 ≥98% 228559-41-9 25mg $234 2024-03-01 Buy
Cayman Chemical 18004 Ki8751 ≥98% 228559-41-9 50mg $437 2024-03-01 Buy
Product number Packaging Price Buy
676484 5mg $303 Buy
18004 5mg $61 Buy
18004 10mg $112 Buy
18004 25mg $234 Buy
18004 50mg $437 Buy

Ki8751 Chemical Properties,Uses,Production

Description

Ki8751 (228559-41-9) is a very potent (IC50 = 0.9 nM) inhibitor of vascular endothelial growth factor receptor 2 (VEGFR-2).1 It also inhibited PDGFRα (IC50 = 67 nM), c-Kit (IC50 = 40 nM), and FGFR2 (IC50 = 170 nM). Ki8751 completely suppressed HUVEC growth at 1 nM. Ki8751 completely inhibited tumor growth in LC-6 human tumor xenografts @ 5mg/kg. Ki8751 displayed anti-influenza A and B activity via disruption of virus entry in a PDGFR?/GM3-dependent manner.2

Uses

Ki8751 is a potent and selective inhibitor of VEGFR2, PDGFRα and c-Kit with IC50 of 0.9 nM, 67 nM and 40 nM, respectively.

Uses

KI 8751 is a potent and selective inhibitor of VEGFR-2-tyrosine kinase which inhibits proliferation of human umbilical vein endothelial cells and inhibits tumor growth.

Definition

ChEBI: 1-(2,4-difluorophenyl)-3-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]-2-fluorophenyl]urea is an aromatic ether.

General Description

A cell-permeable quinolyloxyphenyl-urea compound that acts as a VEGFR-2-selective inhibitior in both cell-based (IC50 = 0.9 nM in VEGF-induced receptor phosphorylation) and cell-free (IC50 = 4.0 nM in kinase reactions) assays. It inhibits c-Kit, PDGFRα, and FGFR-2 only at much higher concentrations (IC50 = 40, 67, and 170 nM, respectively, in cell-based assays), while exhibiting no effect against eight other commonly studied receptor and non-receptor kinases even at concentrations as high as 10 μM. Effectively blocks VEGF-dependent, but not VEGF-independent, cell proliferation in vitro and tumor growth in mice and rats (5 to 20 mg/kg, daily p.o.) in vivo.

Biological Activity

Potent, selective inhibitor of VEGFR-2 tyrosine kinase (IC 50 = 0.9 nM). Displays some inhibitory activity towards c-Kit, PDGFR α and FGFR-2 (IC 50 values range from 40 to 170 nM) but is highly selective over other receptor tyrosine kinases (IC 50 > 10000 nM for FGFR-2, EGFR and HGFR). Inhibits VEGF-stimulated proliferation of human umbilical vein endothelial cells (HUVEC) and inhibits tumor growth in vivo ; antiangiogenic.

storage

Store at +4°C

References

Kubo et al. (2005), Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure-activity relationships, and antitumor activities of N-phenyl-N’{4-(4-quinolyloxy)phenyl}ureas; J. Med. Chem. 48 1359 Vrijens et al. (2019), Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor b signaling pathway; J. Gen. Virol. 100 583

Ki8751 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 121)Suppliers
Supplier Tel Email Country ProdList Advantage
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32480 60
career henan chemical co
+86-0371-86658258 sales@coreychem.com China 29914 58
Hubei Jusheng Technology Co.,Ltd.
18871490254 linda@hubeijusheng.com CHINA 28180 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873 sales@chemdad.com China 39916 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 47465 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 19892 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 29271 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471 sales@sarms4muscle.com China 10523 58
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6393 58
Hebei Duling International Trade Co. LTD
+8618032673083 sales05@hbduling.cn China 15745 58

View Lastest Price from Ki8751 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
	Ki8751 pictures 2019-09-02 Ki8751
228559-41-9
US $7.00 / KG 1KG 99% JD 524 Career Henan Chemical Co
  • 	Ki8751 pictures
  • Ki8751
    228559-41-9
  • US $7.00 / KG
  • 99%
  • Career Henan Chemical Co
Ki8751 hydrate Ki8751, >=98% KI8751;KI 8751;KI-8751 VEGFR2 Kinase Inhibitor VI, Ki8751 Ki8751 1-(2,4-Difluoro-phenyl)-3-[4-(6,7-dimethoxy-quinolin-4-yloxy)-2-fluoro-phenyl]-urea hydrate N-(2,4-Difluorophenyl)-N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]-2-fluorophenyl]urea 1-(2,4-difluorophenyl)-3-(4-(6,7-diMethoxyquinolin-4-yloxy)-2-fluorophenyl)urea N-(2,4-Difluorophenyl)-N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]-2-fluorophenyl]urea KI8751 VEGFR2 Kinase Inhibitor VI, Ki8751 - CAS 228559-41-9 - Calbiochem KI 8751; KI-8751 CS-532 Urea, N-(2,4-difluorophenyl)-N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]-2-fluorophenyl]- Ki8751 USP/EP/BP VEGFR2 Kinase Inhibitor VI Ki8751 Ki-8751 228559-41-9 28559-41-9 C24H18F3N3O4 Inhibitors